(Q48399900)

11 February 2018

title

Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme (English)

1 reference

11 February 2018

0 references

1 reference

14

1 reference

11 February 2018

Karen J. Marcus

3

object named as

Karen J Marcus

1 reference

11 February 2018

author name string

Christopher D Turner

1

1 reference

11 February 2018

Susan Chi

2

1 reference

11 February 2018

Tobey MacDonald

4

1 reference

11 February 2018

Roger J Packer

5

1 reference

11 February 2018

Tina Young Poussaint

6

1 reference

11 February 2018

Sridhar Vajapeyam

7

1 reference

11 February 2018

Nicole Ullrich

8

1 reference

11 February 2018

Liliana C Goumnerova

9

1 reference

11 February 2018

R Michael Scott

10

1 reference

11 February 2018

Caitlin Briody

11

1 reference

11 February 2018

Christine Chordas

12

1 reference

11 February 2018

Mary Ann Zimmerman

13

1 reference

11 February 2018

publication date

22 September 2006

1 reference

11 February 2018

Journal of Neuro-Oncology

published in

1 reference

11 February 2018

volume

82

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

95-101

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/s11060-006-9251-9

exact match

0 references

cites work

Properties of thalidomide and its analogues: implications for anticancer therapy

1 reference

12 December 2020

A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas?

1 reference

12 December 2020

Thalidomide neuropathy in childhood

1 reference

12 December 2020

Combined thalidomide and temozolomide treatment in patients with glioblastoma multiforme

1 reference

12 December 2020

Pediatric brain stem gliomas: a review

1 reference

12 December 2020

Dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in pediatric patients

1 reference

12 December 2020

Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas

1 reference

12 December 2020

Thalidomide: a new anticancer drug?

1 reference

12 December 2020

Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications

1 reference

12 December 2020

Outcome and long-term side effects after synchronous radiochemotherapy for childhood brain stem gliomas

1 reference

12 December 2020

A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma

1 reference

12 December 2020

Brainstem Gliomas. A 10-year institutional review

1 reference

12 December 2020

Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A Childrens Cancer Group Phase I/II Trial

1 reference

12 December 2020

Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer Group

1 reference

12 December 2020

Immunomodulatory drugs.

1 reference

12 December 2020

Diffuse medulla oblongata and pontine gliomas in childhood. A review of 37 cases

1 reference

12 December 2020

Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme

1 reference

12 December 2020

Chemotherapy for brain stem gliomas

1 reference

12 December 2020

Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas

1 reference

12 December 2020

Thalidomide as an anti-angiogenic agent in relapsed gliomas

1 reference

12 December 2020

Brainstem gliomas in children. A Children's Cancer Group review of 119 cases

1 reference

12 December 2020

Clinical management of brain stem glioma

1 reference

12 December 2020

10.1007/S11060-006-9251-9

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018